343 related articles for article (PubMed ID: 33716986)
1. Harnessing Proliferation for the Expansion of Stem Cell-Derived Pancreatic Cells: Advantages and Limitations.
Oakie A; Nostro MC
Front Endocrinol (Lausanne); 2021; 12():636182. PubMed ID: 33716986
[TBL] [Abstract][Full Text] [Related]
2. Establishment of human pluripotent stem cell-derived pancreatic β-like cells in the mouse pancreas.
Ma H; Wert KJ; Shvartsman D; Melton DA; Jaenisch R
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3924-3929. PubMed ID: 29599125
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Differentiation of Stem Cell-derived Human Pancreatic Progenitors to Treat Type 1 Diabetes.
Maloy MH; Ferrer MA; Parashurama N
Stem Cell Rev Rep; 2020 Dec; 16(6):1139-1155. PubMed ID: 32844324
[TBL] [Abstract][Full Text] [Related]
4. In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cells.
Cierpka-Kmiec K; Wronska A; Kmiec Z
Folia Histochem Cytobiol; 2019; 57(1):1-14. PubMed ID: 30869153
[TBL] [Abstract][Full Text] [Related]
5. Biliary tree stem cells, precursors to pancreatic committed progenitors: evidence for possible life-long pancreatic organogenesis.
Wang Y; Lanzoni G; Carpino G; Cui CB; Dominguez-Bendala J; Wauthier E; Cardinale V; Oikawa T; Pileggi A; Gerber D; Furth ME; Alvaro D; Gaudio E; Inverardi L; Reid LM
Stem Cells; 2013 Sep; 31(9):1966-79. PubMed ID: 23847135
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of islets derived from human fetal pancreatic progenitor cells in diabetes treatment.
Zhang WJ; Xu SQ; Cai HQ; Men XL; Wang Z; Lin H; Chen L; Jiang YW; Liu HL; Li CH; Sui WG; Deng HK; Lou JN
Stem Cell Res Ther; 2013; 4(6):141. PubMed ID: 24268157
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Culture of Self-renewing Pancreatic Progenitors Derived from Human Pluripotent Stem Cells.
Trott J; Tan EK; Ong S; Titmarsh DM; Denil SLIJ; Giam M; Wong CK; Wang J; Shboul M; Eio M; Cooper-White J; Cool SM; Rancati G; Stanton LW; Reversade B; Dunn NR
Stem Cell Reports; 2017 Jun; 8(6):1675-1688. PubMed ID: 28591650
[TBL] [Abstract][Full Text] [Related]
8. In vitro differentiation and expansion of human pluripotent stem cell-derived pancreatic progenitors.
Chmielowiec J; Borowiak M
Rev Diabet Stud; 2014; 11(1):19-34. PubMed ID: 25148365
[TBL] [Abstract][Full Text] [Related]
9. An arduous journey from human pluripotent stem cells to functional pancreatic β cells.
Loo LSW; Lau HH; Jasmen JB; Lim CS; Teo AKK
Diabetes Obes Metab; 2018 Jan; 20(1):3-13. PubMed ID: 28474496
[TBL] [Abstract][Full Text] [Related]
10. Lessons from Human Islet Transplantation Inform Stem Cell-Based Approaches in the Treatment of Diabetes.
Triolo TM; Bellin MD
Front Endocrinol (Lausanne); 2021; 12():636824. PubMed ID: 33776933
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Differentiation of Pluripotent Stem Cells into Functional β Islets Under 2D and 3D Culture Conditions and In Vivo Preclinical Validation of 3D Islets.
Bose B; Sudheer PS
Methods Mol Biol; 2016; 1341():257-84. PubMed ID: 25783769
[TBL] [Abstract][Full Text] [Related]
12. Reduced replication fork speed promotes pancreatic endocrine differentiation and controls graft size.
Sui L; Xin Y; Du Q; Georgieva D; Diedenhofen G; Haataja L; Su Q; Zuccaro MV; Kim J; Fu J; Xing Y; He Y; Baum D; Goland RS; Wang Y; Oberholzer J; Barbetti F; Arvan P; Kleiner S; Egli D
JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33529174
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic progenitors: The shortest route to restore islet cell mass.
Venkatesan V; Gopurappilly R; Goteti SK; Dorisetty RK; Bhonde RR
Islets; 2011; 3(6):295-301. PubMed ID: 21934353
[TBL] [Abstract][Full Text] [Related]
14. Cell Mass Increase Associated with Formation of Glucose-Controlling β-Cell Mass in Device-Encapsulated Implants of hiPS-Derived Pancreatic Endoderm.
Robert T; De Mesmaeker I; Van Hulle FO; Suenens KG; Stangé GM; Ling Z; Haller C; Bouche N; Keymeulen B; Kraus MRC; Pipeleers DG
Stem Cells Transl Med; 2019 Dec; 8(12):1296-1305. PubMed ID: 31379140
[TBL] [Abstract][Full Text] [Related]
15. How to make insulin-producing pancreatic β cells for diabetes treatment.
Lu J; Xia Q; Zhou Q
Sci China Life Sci; 2017 Mar; 60(3):239-248. PubMed ID: 27796637
[TBL] [Abstract][Full Text] [Related]
16. Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice.
Rezania A; Bruin JE; Riedel MJ; Mojibian M; Asadi A; Xu J; Gauvin R; Narayan K; Karanu F; O'Neil JJ; Ao Z; Warnock GL; Kieffer TJ
Diabetes; 2012 Aug; 61(8):2016-29. PubMed ID: 22740171
[TBL] [Abstract][Full Text] [Related]
17. Insights from single cell studies of human pancreatic islets and stem cell-derived islet cells to guide functional beta cell maturation in vitro.
Ng NHJ; Neo CWY; Ding SSL; Teo AKK
Vitam Horm; 2021; 116():193-233. PubMed ID: 33752818
[TBL] [Abstract][Full Text] [Related]
18. Concise Review: Markers for Assessing Human Stem Cell-Derived Implants as β-Cell Replacement in Type 1 Diabetes.
Pipeleers D; Robert T; De Mesmaeker I; Ling Z
Stem Cells Transl Med; 2016 Oct; 5(10):1338-1344. PubMed ID: 27381993
[TBL] [Abstract][Full Text] [Related]
19. Islet-like organoids derived from human pluripotent stem cells efficiently function in the glucose responsiveness in vitro and in vivo.
Kim Y; Kim H; Ko UH; Oh Y; Lim A; Sohn JW; Shin JH; Kim H; Han YM
Sci Rep; 2016 Oct; 6():35145. PubMed ID: 27731367
[TBL] [Abstract][Full Text] [Related]
20. Pluripotent Stem Cell-Derived Pancreatic Progenitors and β-Like Cells for Type 1 Diabetes Treatment.
Sambathkumar R; Migliorini A; Nostro MC
Physiology (Bethesda); 2018 Nov; 33(6):394-402. PubMed ID: 30303772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
